News | Cardiovascular Surgery | April 30, 2018

Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes

Results of the 13-year Massachusetts experience of CABG public reporting highlighted at the AATS 98th Annual Meeting

Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes

April 30, 2018 – Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with better patient outcomes compared to national findings, according to a recent study. Results of the 13-year Massachusetts experience were presented in a plenary session of the American Association for Thoracic Surgery’s 98th Annual Meeting.

“State-mandated public reporting of CABG results has been conducted among the 14 Massachusetts cardiac surgery programs since 2002,” explained David M. Shahian, M.D., professor of surgery, Harvard Medical School, and vice-president, Center for Quality and Safety, Massachusetts General Hospital, who led the investigation. “In the current study, we analyzed trends in observed and expected mortality rates and risk factor prevalences, as well as evidence for risk aversion and adverse consequences of outlier designation.”

Investigators compared observed and expected outcomes and risk factor prevalences in Massachusetts with contemporaneous national data from the Society of Thoracic Surgeons (STS) National Database. They also studied the potential association of outlier status with subsequent decreases in market share and expected mortality, the latter a possible indicator of risk aversion. The authors analyzed three populations of adults 18 years or older undergoing isolated CABG surgery between 2003 and 2014:

  • Isolated CABG cases in all non-federal Massachusetts hospitals submitted to the Massachusetts Data Analysis Center, or Mass-DAC, which administered the public reporting program (Mass-DAC cohort);
  • Isolated CABG procedures submitted to STS from all US states other than Massachusetts (national [STS] cohort); and
  • Isolated CABG cases submitted directly to STS from Massachusetts hospitals (MA [STS] cohort).

CABG volume decreases from 2002 to 2014 were less in Massachusetts than in national [STS] data or in New York, another state with mandatory public reporting. Mass-DAC procedure and vital status data were complete and highly accurate. Many risk factor prevalences were similar to those of national [STS] data, although several uncommon but high-risk characteristics — including preoperative cardiogenic shock, emergency status or heart attack within 24 hours preceding surgery — were significantly less common in Massachusetts. Some but not all those differences resulted from a novel peer-adjudication process in Massachusetts. This provided additional scrutiny of cases submitted by hospitals with these codes, some of which were changed, especially in the early years of the public reporting program.

Cardiac surgery public reporting was associated with excellent mortality outcomes. Using identical STS risk models, Massachusetts expected mortality rates were higher than national [STS] rates in the early years of the Massachusetts public reporting program, then subsequently tracked national [STS] expected rates closely. Massachusetts annual observed and risk-adjusted mortality rates were consistently lower than national [STS] rates, as were the ratios of observed to expected mortality (O/E). For two programs that received an outlier designation during the study period, the impacts on subsequent expected mortality rates and market shares were variable and transient.

Possible explanations for better performance in Massachusetts, which the data cannot differentiate, include the salutary effects of public reporting, as described in New York, another public reporting state. However, there are also other potential explanations, including Massachusetts Determination of Need regulations that result in fewer but higher volume programs, and the fact that most Massachusetts cardiac surgery programs are in major tertiary centers or their affiliates. Both procedural volume and teaching intensity have previously been shown to be associated with better healthcare outcomes. The last and most controversial potential explanation is risk aversion, the avoidance of high-risk cases because of their feared impact on report card scores, reputations and referrals. The evidence for this practice in the study by Shahian and colleagues was mixed, with lower prevalences of several high-risk characteristics, but overall expected mortality rates in Massachusetts that were higher than, or no different than, national [STS] rates, and risk-adjusted rates and O/E ratios that were consistently better.

“The bottom line is that mandatory public reporting was consistently associated with better outcomes, although a causal relationship cannot be proven, and there was conflicting and inconclusive evidence for risk aversion”, commented Shahian.

For more information: www.aats.org

 

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init